Nanosphere to Present at Canaccord Genuity Medical Technology & Diagnostics Forum

company logo

NORTHBROOK, Ill., Nov. 29, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William Moffitt, Nanosphere's president and chief executive officer, will present at the Canaccord Genuity Medical Technology & Diagnostics Forum taking place at the Le Parker Meridien Hotel in New York City on Tuesday, December 4, 2012 at 1:30 p.m. ET.

About Nanosphere, Inc.

Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for detection of life threatening infections and cardiovascular diseases. This easy to use and cost effective platform enables simple, low cost and highly sensitive genomic and protein testing on a single platform. Nanosphere is based in Northbrook, IL. Additional information is available at

The Nanosphere, Inc. logo is available at

CONTACT: Investors: Nanosphere, Inc. Roger Moody, 847-400-9021 Chief Financial Officer Media: The Torrenzano Group Ed Orgon, 212-681-1700

Source:Nanosphere, Inc.